Skip to main content
Caplight Logo









BioAZ

BioAZ

Private
FranceHealthcare & Life Scienceshttps://www.bioaz.vet/

Last Round

Seed

Jan 6, 2026

Total Funding Raised

$1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BioAZ is a biotechnology company that develops innovative immunotherapies for animal health and welfare, focusing on sustainable and ethical solutions for livestock and companion animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

immunotherapyanimal healthveterinary biotechnologyVHHcamelid antibodiesimmunocastrationswine healthboar taintanimal welfaresustainable farmingbiotech startupdrug discoveryagtechvet techlivestock innovation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioAZ Comparables

Compare BioAZ with similar companies based on industry and business-model similarity.

BioAZ comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zoetis Inc.
72%
Epivara Inc.
72%
Ceva Santé Animale
64%

BioAZ Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 6, 2026

Key People

Founding team and executive leadership

Romain Delcombel

Co-Founder & CEO

Founding Team

BioAZ Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors increased 1256% MoM.

  • Jan 6, 2026

    $1M round from multiple angel investors.

BioAZ Filings

Explore SEC and related filing metadata, where available.

BioAZ filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioAZ's valuation, stock price, and market status.

Is BioAZ a public or private company?

BioAZ is a private company.

What is the current stock price of BioAZ?

BioAZ is a private company with no public stock price. Caplight tracks BioAZ's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is BioAZ worth (valuation)?

Valuation information for BioAZ is not publicly available.

Can I buy BioAZ stock?

BioAZ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioAZ's last funding round?

BioAZ's most recent funding round was Seed on January 6, 2026.

Who are the main investors in BioAZ?

Key investors in BioAZ include Cercle des Vétérinaires Investisseurs, Veterinary Angel Network for Entrepreneurs, Animal Health Angels.

Will BioAZ IPO soon?

No public IPO plans have been announced for BioAZ.

How can I track BioAZ secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioAZ's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrance
Employee Range5
Year Founded2022
Last FundingJan 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?